Autologous Serum Eyedrops in the Treatment of Aniridic Keratopathy
Authors:
- J.S. López-GarcíaJLJ.S. López-García
- L. RivasLRL. Rivas
- I. García-LozanoIGI. García-Lozano
- J. MurubeJMJ. Murube
- 1 February 2008
- journal article
- research article
- Published by Elsevier in Ophthalmology
- Vol. 115 (2) , 262-267
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Association of Aniridia and Dry EyesOphthalmology, 2005
- Autologous serum application in the treatment of neurotrophic keratopathy*1Ophthalmology, 2004
- Requirement for Pax6 in corneal morphogenesis: a role in adhesionJournal of Cell Science, 2003
- Corneal Abnormalities inPax6+/−Small Eye Mice Mimic Human Aniridia-Related KeratopathyInvestigative Ophthalmology & Visual Science, 2003
- Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host diseaseBone Marrow Transplantation, 2003
- Comparison of Protein Kinase C Subtype Expression Between Normal and Aniridic Human Ocular Surfaces: Implications for Limbal Stem Cell Dysfunction in AniridiaCornea, 1996
- The human PAX6 gene is mutated in two patients with aniridiaNature Genetics, 1992
- Topographical distribution of ocular surface cells by the use of impression cytologyActa Ophthalmologica, 1991
- Beneficial Effect of Artificial Tears Made with Autologous Serum in Patients with Keratoconjunctivitis SiccaArthritis & Rheumatism, 1984
- Die Aniridie als eine Entwicklungshemmung der RetinaGraefe's Archive for Clinical and Experimental Ophthalmology, 1909